InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by MATHIESEN JEFFREY S, Chief Financial Officer. Director active across 3 companies, notably Helius Medical Technologies, INC.. In total, 11 reports have been published. Total volume traded: €28k. The latest transaction was disclosed on 31 May 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations11 total
029,240 shares0
Common Stock
SEC:0001596771-22-000017:0·
08,011 shares0
Class A Common Stock
SEC:0001209191-22-011221:0·
08,011 shares0
Class A Common Stock
SEC:0001209191-22-011221·
€14,0543,000 shares@ €4.68480.011% mcap100.0% of flow
Class A Common Stock
SEC:0001209191-21-070472·
Ideal exit: 13 Sept 2022 (T+270)
€14,0543,000 shares@ €4.68480.011% mcap50.0% of flow
Class A Common Stock
SEC:0001209191-21-070472:0·
Ideal exit: 13 Sept 2022 (T+270)
04,592 shares0
Common Stock
SEC:0001596771-21-000039·
04,592 shares0
Common Stock
SEC:0001596771-21-000039:0·
0937 shares0
Class A Common Stock
SEC:0001209191-21-036235·
04,316 shares0
Common Stock
SEC:0001437749-21-013593·
0937 shares0
Class A Common Stock
SEC:0001209191-21-036235:0·
04,316 shares0
Common Stock
SEC:0001437749-21-013593:0·
11 of 11 declarations
About MATHIESEN JEFFREY S
Jeffrey S. Mathiesen is the Chief Financial Officer and Treasurer at Helius Medical Technologies, Inc., Panbela Therapeutics, Inc., and NeuroOne Medical Technologies Corp. He oversees financial operations and contributes to the overall strategy of these companies.
